Atlas Trials

Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer

Clinical trial NCT01499303 · COMPLETED

Trial details

NCT number
NCT01499303
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-Cell Lymphoma
Start date
2011-12-01
Primary completion
2013-10-01
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.